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An aspartate to lysine mutation at position 13 of the
chemotaxis regulatory protein CheY causes a constitu-
tive tumbly phenotype when expressed at high copy
number in vivo even though the mutant protein is not
phosphorylatable. These properties suggest that the
D13K mutant adopts the active, signaling conformation
of CheY independent of phosphorylation, so knowledge
of its structure could explain the activation mechanism
of CheY. The x-ray crystallographic structure of the
CheY D13K mutant has been solved and refined at 2.3 Å
resolution to an R-factor of 14.3%. The mutant molecule
shows no significant differences in backbone conforma-
tion when compared with the wild-type, Mg21-free struc-
ture, but there are localized changes within the active
site. The side chain of lysine 13 blocks access to the
active site, whereas its e-amino group has no bonding
interactions with other groups in the region. Also in the
active site, the bond between lysine 109 and aspartate 57
is weakened, and the solvent structure is perturbed.
Although the D13K mutant has the inactive conforma-
tion in the crystalline form, rearrangements in the ac-
tive site appear to weaken the overall structure of that
region, potentially creating a metastable state of the
molecule. If a conformational change is required for
signaling by CheY D13K, then it most likely proceeds
dynamically, in solution.
Cells continuously monitor various chemical and physical
parameters in their surrounding environment and use this
information to implement appropriate adaptive responses to
changing conditions. This vital task is accomplished by a cas-
cade of transient protein phosphorylation and dephosphoryl-
ation events arranged so that the flow of phosphoryl groups
reflects environmental conditions. One ubiquitous class of sig-
nal transduction networks is the “two-component” regulatory
systems that control diverse processes such as behavior, devel-
opment, physiology, and virulence in bacteria, as well as adapt-
ive processes in eukaryotes (for reviews, see Refs. 1–4). The
first component is a histidine protein kinase, which autophos-
phorylates using ATP as the phosphodonor. The second com-
ponent is a response regulator protein, which transfers the
phosphoryl group from the histidine protein kinase to itself.
Response regulators are also capable of autophosphorylation
using small molecule phosphodonors such as acetyl phosphate
(5, 6). Phosphorylation alters the activity of the response reg-
ulator, thereby generating a response (e.g. change in gene
expression) to the environmental stimulus.
Our goal is to understand in atomic detail the effects of
phosphorylation on response regulator structure and function.
The best characterized response regulator is the bacterial che-
motaxis protein CheY, which has been the subject of extensive
genetic, biochemical, and biophysical analyses. Phosphorylated
CheY (CheY-P)1 causes flagellar rotation to change from the
default counterclockwise direction to clockwise (7–10). The co-
ordination of changes in swimming behavior with the temporal
changes in chemical concentrations experienced by cells swim-
ming in chemical gradients results in chemotaxis (11, 12).
The three-dimensional structure of CheY has been solved by
both x-ray crystallography (13–16) and multidimensional NMR
(17–19). Response regulator active sites are formed from five
highly conserved residues of the response regulator super-
family (20). In CheY, these are Asp12 and Asp13, involved in
binding a Mg21 ion essential for the phosphorylation and de-
phosphorylation reactions (15, 16, 21); Asp57, the site of phos-
phorylation (22); Thr87, implicated in the postphosphorylation
signaling events (23); and Lys109, also required for postphos-
phorylation steps in the signaling pathway (24). The structure
of CheY-P has not yet been determined due to the fact that the
phosphoryl group has a half-life of only a few seconds on CheY
(8, 9).
We adopted a mutational approach to determine the active
conformation of CheY. Phosphorylation is not the only route to
response regulator activation. Mutations that result in consti-
tutive activity have been isolated for many response regulators.
In the case of CheY, replacement of Asp13 with lysine (the
D13K mutant) results in clockwise flagellar rotation (25, 26).
Genetic evidence that the CheY D13K protein is activated in
the absence of phosphorylation implies that the phosphoryl
group does not play a direct role in the mechanism of CheY
signal transduction, such as phosphotransfer to a downstream
protein, or direct binding (25, 26). These results, plus biochem-
ical evidence that CheY activation does not involve a change to
a multimeric state (25, 27), lead to the conclusion that the
indirect role of phosphorylation is to generate a conformational
change that allows CheY to interact productively with the
flagellar switch. NMR data show that CheY undergoes a con-
formational change upon phosphorylation (28, 29). Presum-
ably, this conformational change is mimicked by constitutively
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active mutants such as CheY D13K. The two routes of activa-
tion (phosphorylation versus the D13K mutation) are thought
to have the same mechanistic features because Lys109 is essen-
tial for both (24, 26). We therefore solved the x-ray crystal
structure of the D13K CheY mutant to find the activated con-
formation of CheY.
MATERIALS AND METHODS
Protein Purification—CheY D13K was purified as described previ-
ously (30), except on a larger scale. A 100 liter culture of KO641recA/
pRBB40.13DK (25) was grown in LB 1 100 mg/ml ampicillin in a
fermentor at 37 °C. Expression of CheY D13K was induced at a cell
turbidity of A595 5 1 by addition of 3b-indoleacrylic acid to 100 mg/ml
final concentration. Cells were harvested after 2 h. Approximately 11
liters of cell paste were lysed by sonication and clarified by centrifuga-
tion. TEDG buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2 mM dithi-
othreitol, and 10% v/v glycerol) was used throughout the purification
procedure. The cell lysate was loaded onto a 2.5 3 10 cm (50 ml) Affi-Gel
Blue column, washed, and eluted with a 0–0.6 M NaCl gradient. Two
passes were required on the Blue column to separate the D13K from the
flow-through. The fractions containing the D13K were pooled, desalted
by dilution, and concentrated in a stirred cell ultrafiltration unit with a
PM10 membrane (Amicon, Inc.). The concentrated D13K was loaded on
a 2.5 3 10 cm (50 ml) DEAE-Sepharose CL-6B column and immediately
eluted with 0.025 M NaCl. CheY D13K was found to bind to DEAE less
tightly than wild-type CheY, presumably due to the 12 charge change
resulting from the mutation. Finally, all fractions containing D13K
were pooled, concentrated with Centricon-10 concentrators (Amicon,
Inc.), and applied to a Superose 12 HR16/50 fast protein liquid chro-
matography gel filtration column (Pharmacia Biotech Inc.). Fractions
containing pure D13K were stored at 220 °C.
Approximately half of the CheY D13K (molecular mass 5 14 kDa)
passed through the PM10 filter (molecular mass cutoff 10 kDa) at the
pre-DEAE step. Passage through the filter resulted in substantial pu-
rification, so this material was retrieved, concentrated in a stirred cell
ultrafiltration unit with a YM5 membrane (Amicon, Inc.), and chro-
matographed separately on the DEAE column. The overall yield from
both halves of the purification process was 28 mg of D13K.
Protein Crystallization—The purified protein was precipitated in a
solution of 3.2 M ammonium sulfate, centrifuged, redissolved in a min-
imal volume of 80 mM ammonium sulfate, 50 mM Tris-HCl, pH 8.3, and
brought to a final concentration of 15 mg/ml. The protein was then
loaded into 20-ml microdialysis chambers, each sealed with dialysis
membrane. Ammonium sulfate was the precipitant used in the crystal-
lization trials. The critical ammonium sulfate concentration for nucle-
ation and crystallization was found to be 2.2 M. The pulsed-diffusion
method (31) was used as described previously (32) for optimization of
crystal size and quality, where graduated up- and down-pulses were
explored over the range of 0.1–2.5 M ammonium sulfate. The crystal
used for data collection grew to dimensions of 0.90 3 0.08 3 0.08 mm.
Mg21 is required in the phosphorylation and dephosphorylation re-
actions of wild-type CheY (5, 21, 33). However, Mg21 binding to CheY
D13K is not detectable by either resonance shifts in 19F NMR spectra of
4-fluorophenylalanine-labeled protein or by quenching of Trp58 fluores-
cence (28, 34). Lack of metal ion binding to the mutant protein is
consistent with the observation that in wild-type CheY, Asp13 is directly
involved in coordination of the Mg21 ion (15, 16). Furthermore, D13K is
phosphorylated only very slowly in the presence of the histidine protein
kinase CheA and ATP (26, 27), and apparently not at all in the presence
of acetyl phosphate (34). Thus, crystallization of CheY D13K in the
absence of both Mg21 and phosphate is biologically relevant.
Crystallographic Data Collection and Processing—Crystals of the
CheY D13K mutant were indistinguishable from those of wild-type
CheY, belonging to the orthorhombic space group P212121, with unit cell
dimensions of a 5 45.9 Å, b 5 47.0 Å, and c 5 54.0 Å. Diffraction data
were collected from one crystal at the area detector facility at Argonne
National Laboratory. The crystal was exposed for a total of ;42 h in
graphite monochromatized Cu Ka radiation from a rotating anode x-ray
generator (50 kV, 100 mA) passing through a 0.3-mm collimator. Data
were recorded at a crystal to detector distance of 100 mm on a Siemens
multiwire area detector, with a swing angle of 15° in 2u for a theoretical
upper resolution limit of 2.26 Å. Data processing and reduction was
done using the XENGEN program package (35). The cell parameters
determined by XENGEN deviated from wild-type by only 0.26%. The
final data set included a total of 12,828 observations of 5,820 unique
reflections ranging from infinity to 2.26 Å. The unweighted absolute
R-factor on intensities for merging all reflections was 6.02%. Statistics
for the final data set used in the structural solution are given in Table I.
Phasing and Structural Refinement—Because the CheY D13K crys-
tals were isomorphous with those of wild-type apoCheY, phasing of the
D13K structure was initiated with a phase calculation using the wild-
type structure with all solvent molecules excluded, and residue 13 was
modeled as an alanine. Refinement of atomic positions was done using
the restrained least squares method (36). The R-factor smoothly con-
verged to a final value of 14.3% after a total of 110 cycles of refinement
interspersed with 10 partial rebuilds. 4,432 reflections greater than 2s
in the resolution range 10–2.26 Å were used in the final refinement.
The final refinement status is presented in Table II.
Calculations of electron density maps and other data processing were
carried out with the XTAL software package (37) and several locally
developed programs. The least squares refinement was done with the
software packages PROTIN and PROFFT (36, 38). Visualization of the
electron density maps and model rebuilding were done using the graph-
ics package FRODO (39) on an Evans and Sutherland PS300 system.
RESULTS
General Description of Structural Results—The electron den-
sity maps from the final u2Fo 2 Fcuacalc and uFo 2 Fcuacalc
difference Fourier calculations are clear and well defined for
the entire backbone of the molecule. The average thermal pa-
rameters for all protein atoms is 13.8 Å2 (Fig. 1). The final
coordinate set consists of 1108 atoms, of which 1003 are protein
and 105 are solvent molecules with unit occupancies.
TABLE I
Statistics for data and final refinement of Escherichia coli
CheY mutant D13K




`3 10.00 86 96.5 –b –
10.003 4.32 816 100.0 96.9 14.8
4.323 3.43 834 100.0 95.9 11.2
3.433 3.00 826 99.9 92.9 12.5
3.003 2.72 835 97.0 86.5 14.9
2.723 2.52 846 94.4 75.8 17.1
2.523 2.37 822 85.2 64.1 20.6
2.373 2.26 755 31.9 24.4 20.2





b Data intentionally omitted.
TABLE II
Refinement restraints and root mean square deviations from
ideal of the E. coli CheY mutant D13K using 4432 reflections from
10 to 2.26 Å
Parameter Target s Final value
Distance restraints (Å)
Bond distance 0.020 0.016
Angle distance 0.040 0.051
Planar distance 0.050 0.057
Plane restraint (Å) 0.020 0.010
Chiral-center restraint (Å3) 0.150 0.153
Non-bonded contact
restraints (Å)
Single torsion contact 0.500 0.201
Multiple torsion contact 0.500 0.238
Possible hydrogen bond 0.500 0.287
Conformational torsion angle
restraint (Å)
Planar (v, 0°, 180°) 3.0 1.8
Staggered (660°, 180°) 15.0 20.5
Orthonormal (690°) 20.0 17.6
Isotropic thermal factor
restraints (Å2)
Main-chain bond 1.000 0.823
Main-chain angle 1.500 1.431
Side-chain bond 1.000 0.916
Side-chain angle 1.500 1.614
X-ray 0.7*^?Fo 2 Fc?& 14.30%
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Clearly defined electron density for the entire lysine residue
at position 13 confirms the amino acid substitution (Fig. 2). The
amino group of the Lys13 side chain makes no interactions with
other groups of the active site. Instead, the side chain is in a
fairly extended conformation (x1–4 5 70°, 2156°, 152°, and
123°, respectively), where the e-amino group has weak hydro-
gen bonding contacts with external solvent molecules. The
non-ideal value of x4 is due to a close, non-bonding contact of
the terminal group with the side chain of Asn59. Although the
lysine side chain at position 13 appears capable of assuming an
alternate rotameric position (t) away from the active site with
no steric restrictions, its observed position (g2) in the structure
blocks access to the active site, especially the Mg21 binding
region. This is consistent with the fact that the CheY D13K
mutant does not bind Mg21 (34) and exhibits essentially no
phosphorylation ability (26, 27, 34).
Comparison of Wild-type and CheY D13K Structures—A
least squares superposition of the Mg21-free, wild-type, and
D13K mutant CheY structures shows a root mean square dif-
ference in positions of equivalent a-carbon atoms of just 0.21 Å
and reveals only one significant difference in the position of
backbone atoms, 0.71 Å for the a-carbon of Lys13, the site of the
mutational change (Fig. 3).
There are only two side chains that differ in position by any
significant extent between the two structures, Asp12 and Asp57
(Fig. 4). In the CheY D13K structure, Asp12 is rotated by 250°
about its x2 bond, where its Od1 atom establishes a hydrogen
bond with the amide nitrogen of Phe14. Similarly, Asp57 is
rotated by 260° about its x2 bond, so the Asp
57 Od2 atom loses
its hydrogen bond with the amide nitrogen of Asn59. The new
position of the Asp57 side chain is 1.1 Å closer to the Mg21
binding site, a site now unoccupied because of the occlusion by
the Lys13 side chain. This repositioning of Asp57 eliminates its
strong interaction with the e-amino group of Lys109 seen in the
wild-type CheY structure. The only other change in the CheY
D13K mutant is the pronounced lack of order in the solvent
structure of the active site. In wild-type CheY, the active site
contains some of the best ordered solvent molecules, whereas in
the D13K structure, the solvent is poorly ordered and with
much higher temperature factors and weaker hydrogen bond-
ing geometries (Fig. 4).
DISCUSSION
Wild-type CheY and CheY D13K Have the Same Conforma-
tion in the Crystalline State—The presumably inactive, non-
phosphorylated, wild-type CheY and the presumably activated
D13K mutant CheY have backbone conformations in the crys-
talline state that are indistinguishable within experimental
error. There are three possibilities that could account for this
result. First, activation of CheY might not involve a conforma-
tional change. There is at least one example of lack of confor-
mational changes in an enzyme following phosphorylation (40,
41), concerning the regulation of isocitrate dehydrogenase.
FIG. 1. Temperature factor versus residue number for CheY
mutant D13K. Temperature factors for main chain and side chain
groups were calculated from arithmetic averages of their respective
atoms. The average main chain temperature factors for wild-type CheY
are plotted as a continuous line for comparison. A schematic of the
secondary structure elements is included.
FIG. 2. Stereo diagram of the final
z2Fo 2 Fczacalc electron density map of
the D13K mutation site of CheY. The
map was contoured at 1.5s. Parts of the
map, molecule, and solvent between the
viewer and the active site have been re-
moved for clarity.
FIG. 3. rms differences between a-carbon positions of D13K
mutant and wild-type CheY molecules after least squares super-
position. The average rms difference for all a-carbon atoms is 0.21 Å.
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However, this explanation does not apply to CheY because it is
inconsistent with all previous experimental data (25, 27–29) as
described in the Introduction. Second, both proteins might
have crystallized in the active conformation. This is unlikely
because the conformation observed in crystalline CheY D13K is
the same as wild-type, apoCheY, both crystalline (13–15) and
in solution (17–19), and the conformation of wild-type CheY
has been shown to change upon Mg21 binding (15, 16, 18, 28,
42) and phosphorylation (28, 29). Thus, these results strongly
suggest the third possibility that the conformation of D13K
observed here does not represent the activated state of CheY.
There are three possible explanations why the D13K CheY
mutant might have crystallized in an inactive conformation.
First, it might assume the active conformation only upon bind-
ing to the flagellar switch. This seems improbable, and also not
readily testable. Second, in solution, D13K might truly mimic
the phosphorylation-induced conformational changes that are
critical for activation, but lattice forces prevent the solution-
state conformational change from occurring in the crystal. This
seems unlikely in view of the facts that the crystallization
conditions, crystal morphology, space group, and unit cell di-
mensions were identical for Mg21-free, wild-type CheY and
D13K. Finally, the CheY molecule may normally exist in equi-
librium between the active and inactive conformations, and
either phosphorylation or the D13K mutation could serve to
shift a sufficient fraction of the population into the activated
state to generate clockwise flagellar rotation in vivo (Fig. 5).
With this explanation, the observed, crystalline conformation
of CheY D13K would be a metastable state, the conformation of
the inactive majority of the population, which could transform
to the activated form in solution. This possibility is consistent
with results from 1H- and 15N-NMR spectroscopy on CheY
D13K, which allow for a small percent of the D13K mutant
molecule to be in an alternate conformation, rapidly intercon-
verting with its resting state.2
Comparison of Wild-type and CheY D13K Activities—CheY
binds specifically to three different proteins: CheA, which do-
nates the phosphoryl group to CheY (43–46); CheZ, which
stimulates dephosphorylation of CheY-P (43, 47–49); and FliM,
the recipient of the activating signal of CheY, located in the
flagellar switch complex (34, 50). Phosphorylation of wild-type
CheY reduces binding to CheA but enhances binding to CheZ
and FliM. Measurement of the binding affinities between CheY
D13K and each of these three proteins may therefore indicate
the degree of structural similarity between CheY D13K and
CheY-P. D13K binds to CheA with about 2-fold lower affinity
than nonphosphorylated wild-type CheY (46, 51), but its bind-
ing affinities for CheZ (47) and FliM (34) are the same as
nonphosphorylated wild-type rather than the enhanced affini-
ties expected for an activated conformation of CheY-P. Thus,
the in vitro protein binding assays suggest that CheY D13K
only partially assumes the activated conformation in solution.
Several other observations support the hypothesis that CheY
D13K exists in a metastable state, in a conformation that can
easily convert to the activated form. First, the hyper-signaling
activity of CheY D13K is observed in a strain containing a
multicopy plasmid (25) but is substantially reduced when the
mutant protein is expressed from a single copy chromosomal
gene (26). Second, the in vivo activity of wild-type CheY is
increased by simple overexpression (52), and there is evidence
that nonphosphorylated wild-type CheY possesses a low level
of clockwise-generating activity (10). Finally, in the case of2 D. Lowry and F. W. Dahlquist, unpublished observations.
FIG. 4. Comparison of CheY active sites. A, active site of wild-type CheY at 1.7 Å resolution (14). B, active site of CheY D13K at 2.3 Å
resolution. The orientation is approximately the same as in Fig. 2. The solvent molecules are numbered in order of increasing temperature factors
for each structure.
FIG. 5. Schematic diagram of possible activation pathways for
wild-type CheY and CheY D13K.
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another response regulator, OmpR, overproduction of the non-
phosphorylatable mutant D55Q (position 55 being the site of
phosphorylation of OmpR) generates the phenotype character-
istic of wild-type OmpR-P (53).
19F-NMR Results Regarding the Conformational State of
CheY D13K—The CheY molecule contains six phenylalanine
residues. Four of these (Phe8, Phe30, Phe53, and Phe124) are
clustered far from the active site, Phe14 is solvent exposed, and
Phe111 is buried underneath Lys109. 19F-NMR spectra obtained
with 4-fluorophenylalanine-labeled CheY D13K did not show
any differences in the environments of Phe8, Phe30, Phe53, and
Phe124 between wild-type CheY and CheY D13K (26), suggest-
ing that the D13K substitution does not induce a conforma-
tional change in this remote region. This is consistent with the
conformation observed in the CheY D13K crystal structure.
The resonance for 4-fluorophenylalanine-labeled Phe111 was
perturbed, perhaps reflecting an effect of the D13K substitu-
tion on the position of Lys109. However, the environment of
Phe111 is essentially identical in the crystal structures of wild-
type CheY and CheY D13K. The only structural differences in
the crystallographic results involve the two aspartate residues,
Asp12 and Asp57, discussed above, which are more than 7 Å
away from Phe111. Thus, the 19F-NMR work also suggests that
CheY D13K adopts a conformation in solution different than
that observed in the crystal structure presented here.
Conclusions and Possible Mechanisms for CheY D13K Acti-
vation—In summary, the crystal structure of the constitutively
active D13K mutant of CheY surprisingly has no conforma-
tional differences when compared with the Mg21-free form of
the wild-type CheY molecule. Thus the CheY D13K structure
presented here is the inactive form of the molecule, and the
interpretation is that only in solution does this form proceed to
a conformation resembling activated CheY.
In all CheY structures published to date, (14–16, 23, 54, 56),
the Asp57 side chain assumes one of two general positions,
depending upon the presence or absence of a divalent cation
(Mg21 or Ca21) (Fig. 6). In the apo forms, Asp57 and Lys109
have strong bonding interactions, but introduction of Mg21 or
Ca21 eliminates this interaction (15, 16, 54, 56). Phosphoryla-
tion of Asp57 is certain to rearrange the active site even further,
requiring a repositioning of the Lys109 side chain (14). Lys109 is
known to be essential for stimulation of clockwise flagellar
rotation but not for phosphorylation or autodephosphorylation
of CheY (24, 26), and thus, it has a presumed role in the
propagation of a conformational change that causes activation.
The unusual position of the Asp57 side chain in CheY D13K
may reflect a predisposition of this mutant form of CheY to
readily assume the activated conformation in the absence of
phosphorylation.
An alternate activation mechanism is that CheY D13K
might mimic a part of the CheY-P structure that is important
for clockwise signal generation but lacks the conformation
needed for efficient FliM binding since CheY D13K does not
exhibit the enhanced binding to FliM in vitro observed with
wild-type CheY-P (34). The fact that we found D13K in an
“inactive” conformation is consistent with this, again suggest-
ing that the activity resides in only a minor sub-population of
the molecules. Thus it is possible that FliM binding and pro-
motion of clockwise flagellar rotation may be separable events.
It has been proposed elsewhere (10, 34, 55) that binding of
CheY-P to the flagellar motor is a necessary, but not sufficient,
event for signal transduction.
Acknowledgments—We thank E. Westbrook and M. Westbrook for
help and generosity in data collection at Argonne National Laboratory.
REFERENCES
1. Parkinson, J. S., and Kofoid, E. C. (1992) Annu. Rev. Genet. 26, 71–112
2. Parkinson, J. S. (1993) Cell 73, 857–871
3. Swanson, R. V., Alex, L. A., and Simon, M. I. (1994) Trends Biochem. Sci. 19,
485–490
4. Hoch, J. A., and Silhavy, T. J. (1995) Two-Component Signal Transduction,
ASM Press, Washington, D. C.
5. Lukat, G. S., McCleary, W. R., Stock, A. M., and Stock, J. B. (1992) Proc. Natl.
Acad. Sci. U. S. A. 89, 718–722
6. McCleary, W. R., and Stock, J. B. (1994) J. Biol. Chem. 269, 31567–31572
7. Larsen, S. H., Reader, R. W., Kort, E. N., Tso, W.-W., and Adler, J. (1974)
Nature 249, 74–77
8. Wylie, D., Stock, A., Wong, C.-Y., and Stock, J. (1988) Biochem. Biophys. Res.
Commun. 151, 891–896
9. Hess, J. F., Oosawa, K., Kaplan, N., and Simon, M. I. (1988) Cell 53, 79–87
10. Barak, R., and Eisenbach, M. (1992) Biochemistry 31, 1821–1826
11. Berg, H. C., and Brown, D. A. (1972) Nature 239, 500–504
12. Macnab, R. M., and Koshland, D. E., Jr. (1972) Proc. Natl. Acad. Sci. U. S. A.
69, 2509–2512
13. Stock, A. M., Mottonen, J. M., Stock, J. B., and Schutt, C. E. (1989) Nature 337,
745–749
14. Volz, K., and Matsumura, P. (1991) J. Biol. Chem. 266, 15511–15519
15. Stock, A. M., Martinez-Hackert, E., Rasmussen, B. F., West, A. H., Stock, J. B.,
Ringe, D., and Petsko, G. A. (1993) Biochemistry 32, 13375–13380
16. Bellsolell, L., Prieto, J., Serrano, L., and Coll, M. (1994) J. Mol. Biol. 238,
489–495
17. Bruix, M., Pascual, J., Santoro, J., Prieto, J., Serrano, L., and Rico, M. (1993)
Eur. J. Biochem. 215, 573–585
18. Moy, F. J., Lowry, D. F., Matsumura, P., Dahlquist, F. W., Krywko, J. E., and
Domaille, P. J. (1994) Biochemistry 33, 10731–10742
19. Santoro, J., Bruix, M., Pascual, J., Lopez, E., Serrano, L., and Rico, M. (1995)
J. Mol. Biol. 247, 717–725
20. Volz, K. (1993) Biochemistry 32, 11741–11753
21. Lukat, G. S., Stock, A. M, and Stock, J. B. (1990) Biochemistry 29, 5436–5442
22. Sanders, D. A., Gillece-Castro, B. L., Stock, A. M., Burlingame, A. L., and
Koshland, D. E., Jr. (1989) J. Biol. Chem. 264, 21770–21778
23. Ganguli, S., Wang, H., Matsumura, P., and Volz, K. (1995) J. Biol. Chem. 270,
17386–17393
FIG. 6. Plot of x1 versus x2 angles for the aspartate 57 residue of
wild-type CheY and all known mutant structures. The average
values of x1 and x2 are 208° and 84°, respectively, for the apo forms (l),
excluding D13K, and 177° and 33°, respectively, for the cation bound
forms (f). The ellipses enclose a range of four standard deviations for
the two populations. The conformation in D13K is closer to the cation
bound structures and is away from the apo forms. The conformation of
aspartate 57 is shown in Fig. 4A for wild-type and in Fig. 4B for D13K.
The apo structures are wild-type (3chy; Ref. 14); T87I (1vlz, 2 molecules;
Ref. 23); M17G (1ymu, 2 molecules; Ref. 54); T87I/Y106W (6chy, 2
molecules; Ref. 56); and D13K (1ehc, this work). The cation bound
structures are wild-type CheY:Mg21 (2che; Ref. 15; and 1chn; Ref. 16);
F14G/S15G/M16G:Mg21 (1ymv; Ref. 54); and Y106W:Ca21 (5chy; Ref.
56).
2.3 Å X-Ray Structure of CheY Mutant D13K11854
24. Lukat, G. S., Lee, B. H., Mottonen, J. M., Stock, A. M., and Stock, J. B. (1991)
J. Biol. Chem. 266, 8348–8354
25. Bourret, R. B., Hess, J. F., and Simon, M. I. (1990) Proc. Natl. Acad. Sci.
U. S. A. 87, 41–45
26. Bourret, R. B., Drake, S. K., Chervitz, S. A., Simon, M. I., and Falke, J. J.
(1993) J. Biol. Chem. 268, 13089–13096
27. Roman, S. J., Meyers, M., Volz, K., and Matsumura, P. (1992) J. Bacteriol. 174,
6247–6255
28. Drake, S. K., Bourret, R. B., Luck, L. A., Simon, M. I., and Falke, J. J. (1993)
J. Biol. Chem. 268, 13081–13088
29. Lowry, D. F., Roth, A. F., Rupert, P. B., Dahlquist, F. W., Moy, F. J., Domaille,
P. J., and Matsumura, P. (1994) J. Biol. Chem. 269, 26358–26362
30. Hess, J. F., Bourret, R. B., and Simon, M. I. (1991) Methods Enzymol. 200,
188–204
31. Koeppe, R. E., II, Stroud, R. M., Pena, V. A., and Santi, D. V. (1975) J. Mol.
Biol. 98, 155–160
32. Volz, K., Beman, J., and Matsumura, P. (1986) J. Biol. Chem. 261, 4723–4725
33. Hess, J. F., Bourret, R. B., Oosawa, K., Matsumura, P., and Simon, M. I. (1988)
Cold Spring Harbor Symp. Quant. Biol. 53, 41–48
34. Welch, M., Oosawa, K., Aizawa, S.-I., and Eisenbach, M. (1994) Biochemistry
33, 10470–10476
35. Howard, A., Gilliland, G. L., Finzel, B. C., Poulos, T. L., Ohlendorf, D. H., and
Salemme, F. R. (1987) J. Appl. Crystallogr. 20, 383–390
36. Hendrickson, W. A. (1985) Methods Enzymol. 115, 252–270
37. Hall, S. R., and Stewart, J. M. (eds) (1988) XTAL 2.4 User’s Manual, Univer-
sities of Western Australia and Maryland, Perth, Australia
38. Finzel, B. F. (1987) J. Appl. Crystallogr. 20, 53–55
39. Jones, T. A. (1985) Methods Enzymol. 115, 157–171
40. Hurley, J. H., Dean, A. M., Thorsness, P. E., Koshland, D. E., Jr., and Stroud,
R. M. (1990) J. Biol. Chem. 265, 3599–3602
41. Hurley, J. H., Dean, A. M., Sohl, J. L., Koshland, D. E., Jr., and Stroud, R. M.
(1990) Science 249, 1012–1016
42. Kar, L., Matsumura, P., and Johnson, M. E. (1992) Biochem. J. 287, 521–531
43. McNally, D. F., and Matsumura, P. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,
6269–6273
44. Schuster, S. C., Swanson, R. V., Alex, L. A., Bourret, R. B., and Simon, M. I.
(1993) Nature 365, 343–347
45. Swanson, R. V., Schuster, S. C., and Simon, M. I. (1993) Biochemistry 32,
7623–7629
46. Li, J., Swanson, R. V., Simon, M. I., and Weis, R. M. (1995) Biochemistry 34,
14626–14636
47. Blat, Y., and Eisenbach, M. (1994) Biochemistry 33, 902–906
48. Blat, Y., and Eisenbach, M. (1996) J. Biol. Chem. 271, 1226–1231
49. Blat, Y., and Eisenbach, M. (1996) J. Biol. Chem. 271, 1232–1236
50. Welch, M., Oosawa, K., Aizawa, S.-I., and Eisenbach, M. (1993) Proc. Natl.
Acad. Sci. U. S. A. 90, 8787–8791
51. Shukla, D., and Matsumura, P. (1995) J. Biol. Chem. 270, 24414–24419
52. Clegg, D. O., and Koshland, D. E., Jr. (1984) Proc. Natl. Acad. Sci. U. S. A. 81,
5056–5060
53. Kanamaru, K., and Mizuno, T. (1992) J. Biochem. 111, 425–430
54. Bellsolell, L., Cronet, P., Majolero, M., Serrano, L., and Coll, M. (1996) J. Mol.
Biol. 257, 116–128
55. Zhu, X. Y., Amsler, C. A., Volz, K., and Matsumura, P. (1996) J. Bacteriol. 178,
4208–4215
56. Zhu, X. Y., Rebello, J., Matsumura, P., and Volz, K. (1997) J. Biol. Chem. 272,
5000–5006
2.3 Å X-Ray Structure of CheY Mutant D13K 11855
